Why the study?
Does scopolamine cause anticholinergic adverse effects in perioperative patient populations?
Does scopolamine cause anticholinergic adverse effects in perioperative patient populations?
Scopolamine should be avoided in pediatric and older adult perioperative patients due to the risk of anticholinergic adverse effects.
Clinicians should avoid scopolamine in at-risk perioperative patients; extends documentation of anticholinergic effects for safer antiemetic selection.
Scopolamine is an antiemetic agent used for postoperative nausea and vomiting prevention; however, it has anticholinergic effects (eg, bradycardia, dry mouth, dizziness, visual disturbances). Avoiding scopolamine use in specific populations is crucial to prevent adverse effects and harm to patients. This systematic review describes the anticholinergic effects of scopolamine in perioperative patient populations. After searching the available literature, we reviewed the eligible articles to determine whether they met the inclusion criteria (eg, full text, English language, included a discussion of scopolamine's anticholinergic effects in perioperative patients). Twenty-six articles were included in this review. We used The Johns Hopkins Research Evidence Appraisal Tool to appraise the literature. The results of this literature review reveal that clinicians should avoid administering scopolamine to certain perioperative patient populations (ie, pediatric, older adult).
No takes yet. Share an insight, caveat, or question.
Kassel et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: